Farmacias Benavides, S.A.B. de C.V. Share Price
Stocks
BEVIDES B
MXP3895X1106
Drug Retailers
OTC Markets Traded|
End-of-day quote
Mexican S.E.
22/07/2026
|
5-day change | 1st Jan Change | ||
| 25.00 MXN | -.--% |
|
-.--% | -3.85% |
| 07/10 | Canada's Weston family to buy UK's Boots in $8.9 billion deal | RE |
| 31/07 | Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 1.02TCr 54Cr 49Cr 45Cr 41Cr 76Cr 5.17TCr 77Cr 535.73Cr 213.72Cr 2.71TCr 203.94Cr 199.59Cr 8.58TCr | P/E 2024 |
68.9x | P/E 2025 | 47.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.2TCr 64Cr 57Cr 53Cr 48Cr 89Cr 6.05TCr 90Cr 626.64Cr 249.99Cr 3.17TCr 238.55Cr 233.47Cr 10TCr | EV / Sales 2024 |
0.69x | EV / Sales 2025 | 0.64x |
| Free-Float |
16.07% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -3.85% | ||
| Current year | -3.85% |
| Current year | 25 | 26 | |
| 1 year | 25 | 26 | |
| 3 years | 17.5 | 26 | |
| 5 years | 8.3 | 26 | |
| 10 years | 8.3 | 26 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 02/12/2024 | |
| Director of Finance/CFO | - | 17/03/2026 | |
| Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 02/05/2023 | |
Olmo Palermo
BRD | Director/Board Member | - | 01/01/2021 |
| Director/Board Member | - | 02/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | +31.58% | 55Cr | ||
| -1.26% | -7.55% | -42.15% | +0.64% | 1.48TCr | ||
| +0.22% | -2.00% | -10.54% | -2.79% | 626.2Cr | ||
| +1.65% | -0.07% | -16.89% | +1.72% | 616.07Cr | ||
| -1.25% | -6.13% | -53.78% | -40.62% | 574.87Cr | ||
| -15.53% | -26.61% | -18.63% | -38.34% | 510.93Cr | ||
| +1.16% | -1.68% | -1.14% | -9.60% | 452.97Cr | ||
| -0.81% | -5.52% | -17.46% | -21.21% | 301.72Cr | ||
| -0.16% | +1.88% | +0.99% | -22.99% | 315.15Cr | ||
| -4.44% | -10.93% | -42.24% | -18.73% | 298.89Cr | ||
| Average | -2.04% | -5.63% | -20.18% | -12.03% | 523.31Cr | |
| Weighted average by Cap. | -2.00% | -6.03% | -26.37% | -12.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.76TCr 94Cr 84Cr 78Cr 70Cr 131.19Cr 8.93TCr 133.31Cr 924.92Cr 368.99Cr 4.68TCr 352.09Cr 344.6Cr 15TCr | 1.95TCr 103.45Cr 93Cr 85Cr 77Cr 144.66Cr 9.85TCr 147Cr 1.02TCr 406.88Cr 5.16TCr 388.25Cr 379.98Cr 16TCr |
| Net income | 13Cr 69.39L 62.16L 57.34L 51.89L 97.03L 66Cr 98.6L 6.84Cr 2.73Cr 35Cr 2.6Cr 2.55Cr 109.54Cr | 22Cr 1.19Cr 1.07Cr 98.45L 89.09L 1.67Cr 113.46Cr 1.69Cr 12Cr 4.69Cr 59Cr 4.47Cr 4.38Cr 188.07Cr |
| Net Debt | 325.96Cr 17Cr 16Cr 14Cr 13Cr 24Cr 1.65TCr 25Cr 170.85Cr 68Cr 863.66Cr 65Cr 64Cr 2.74TCr | 173.46Cr 9.22Cr 8.26Cr 7.62Cr 6.9Cr 13Cr 878.18Cr 13Cr 91Cr 36Cr 459.6Cr 35Cr 34Cr 1.46TCr |
Employees
7,754
Sector
Drug Retailers
- Stock Market
- Stocks
- BEVIDES B Stock
Select your edition
All financial news and data tailored to specific country editions
















